Business
Salarius secures first commercial order
Salarius secures first commercial order.
About this update from Tekcapital Plc
[{"type":"text","content":"\n \nRNS Number : 7090W Tekcapital plc 23 April 2019 \n\n \n \nThe information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 (\"MAR\"). With the publication of this announcement via a Regulatory Information Service (\"RIS\"), this inside information is now considered to be in the public domain.\n \n23 April 2019\nTekcapital Plc\n(\"Tekcapital\", the \"Company\" or \"the Group\")\nPortfolio Company Update: \nSalarius launches production of MicroSalt® and secures first commercial order \n \nTekcapital Plc (AIM: TEK), the UK intellectual property (IP) investment group focused on creating marketplace value from investing in university technology, is very pleased to announce that its portfolio company Salarius ltd. has launched production of MicroSalt® and secured its first customer to incorporate MicroSalt® in their snack food business. \n \nSalarius is the developer and manufacturer of a remarkable new, proprietary low sodium salt called MicroSalt®. MicroSalt® is made with very small salt particles that have a large surface area-to-volume ratio. This creates a salty taste whilst using significantly less salt.\n \nThe initial order is from a US snack food producer and Salarius expects to dispatch the MicroSalt® in May 2019.\n \nMarket Information\n \nAccording to the World Health Organization1, cardiovascular disease takes the lives of 17.9 million people per year and is responsible for 31% of global deaths. In the U.K., there are about 160,000 deaths from heart disease each year accounting for 26% of all deaths.2 \n \nHigh blood pressure is a key risk factor for developing heart disease. \n \nOn 5 March 2019, a new report from the National Academies of Sciences, Engineering, and Medicine recommending reduced sodium consumption guidelines.3 This report introduces Chronic Disease Risk Reduction (CDRR) intakes for sodium. According to the National Academies of Sciences, Engineering and Medicine: \n \n\"There is sufficient evidence to characterize the relationship between sodium intake and risk of chronic disease. Therefore, the committee established a Chronic Disease Risk Reduction Intake (CDRR) for sodium using evidence of the beneficial effect of reducing sodiu...